• Research Interest
• Clinical Specialties
• Recent Publications
• Honors & Awards
• Training and Certifications
• Contact Information

Research Interest

• Studying the late effects of childhood cancer
• Developing new treatments for sarcomas
• Interest in DNA mutations in cancer development
  

Clinical Specialties

• High-risk sarcomas
• Long term follow up care for survivors of childhood cancer
  

Recent Publications (selected)

• Goldsby RE, Lawrence NA, Hays L, Olmsted E, Xin C, Singh M, Preston BD. Defective DNA polymerase delta proofreading causes cancer susceptibility in mice. Nat Med 7:638-639, 2001.
• Goldsby RE, Lawrence NA, Hays L, Olmsted E, Xin C, Slayton W, Spangrude GJ, Singh M, Preston BD. High incidence of epithelial tumors in mice with defective polymerase proofreading. Proc Natl Acad Sci U S A. 99:15560-5, 2002.
• Goldsby RE, Pulsipher M, Adams R, Coffin C, Albritton K, WagnerL. Pleural effusions in 3 pediatric patients treated with STI-571. J Pediatr Hematol Oncol. 24:694-5, 2002.
• Holly Z, Randall RL, Brothman AR, Maxwell T, Coffin CM, Goldsby RE. HER-2/neu expression in osteosarcoma increases risk of lung metastasis and can be associated with gene amplification. J Pediatr Hematol Oncol 25:27-32, 2003.
• Wagner LM, Crews KR, Iacono LC, Houghton PJ, Fuller CE, McCarville MB, Goldsby RE, Albritton K Stewart CF, Santana VM. Phase I Trial of Temozolomide and Protracted Irinotecan in Pediatric Patients with Refractory Solid Tumors. Clin Cancer Res. 10(3):840-848, 2004
  

Honors & Awards (selected)

• Advanced Training in Clinical Research (ATCR) Certificate, 2003

Training & Certificates

• University of Vermont, Medical Degree
• Children’s Hospital Oakland, Pediatric Residency
• University of Utah Pediatric, Hematology/Oncology Fellowship